<s id="wsj_0552.1"> 14
2 	 1 	 NP[nb]/N 	 1 	 economy the
2 	 3 	 S[dcl]\NP 	 1 	 economy stumbled
3 	 0 	 (S/S)/S[dcl] 	 2 	 stumbled When
3 	 4 	 ((S\NP)\(S\NP))/NP 	 2 	 stumbled in
6 	 4 	 ((S\NP)\(S\NP))/NP 	 3 	 mid-1970s in
6 	 5 	 NP[nb]/N 	 1 	 mid-1970s the
9 	 8 	 N/N 	 1 	 NV Akzo
9 	 10 	 (S[dcl]\NP)/PP 	 1 	 NV fell
10 	 0 	 (S/S)/S[dcl] 	 1 	 fell When
12 	 10 	 (S[dcl]\NP)/PP 	 2 	 of fell
12 	 11 	 PP/PP 	 1 	 of out
13 	 12 	 PP/NP 	 1 	 bed of
<\s>
<s id="wsj_0552.2"> 31
1 	 0 	 N/N 	 1 	 overcapacity Towering
1 	 2 	 (NP\NP)/NP 	 1 	 overcapacity in
1 	 20 	 (S[dcl]\NP)/PP 	 1 	 overcapacity led
1 	 25 	 ((S[dcl]\NP)/PP)/NP 	 1 	 overcapacity left <XU>
6 	 2 	 (NP\NP)/NP 	 2 	 business in
6 	 3 	 NP[nb]/N 	 1 	 business the
6 	 4 	 N/N 	 1 	 business synthetic
6 	 5 	 N/N 	 1 	 business fiber
6 	 8 	 (NP\NP)/(S[dcl]\NP) 	 1 	 business which
6 	 9 	 (S[dcl]\NP)/PP 	 1 	 business accounted <XB>
9 	 8 	 (NP\NP)/(S[dcl]\NP) 	 2 	 accounted which
10 	 9 	 (S[dcl]\NP)/PP 	 2 	 for accounted
11 	 10 	 PP/NP 	 1 	 half for
11 	 12 	 (NP\NP)/NP 	 1 	 half of
16 	 13 	 NP[nb]/N 	 1 	 company the
16 	 14 	 N/N 	 1 	 company Dutch
16 	 15 	 N/N 	 1 	 company chemical
16 	 17 	 (NP[nb]/N)\NP 	 2 	 company 's
18 	 12 	 (NP\NP)/NP 	 2 	 sales of
18 	 17 	 (NP[nb]/N)\NP 	 1 	 sales 's
21 	 20 	 (S[dcl]\NP)/PP 	 2 	 to led
23 	 21 	 PP/NP 	 1 	 losses to
23 	 22 	 N/N 	 1 	 losses huge
26 	 27 	 (NP[nb]/N)\NP 	 2 	 Akzo 's
28 	 25 	 ((S[dcl]\NP)/PP)/NP 	 3 	 survival left
28 	 27 	 (NP[nb]/N)\NP 	 1 	 survival 's
29 	 25 	 ((S[dcl]\NP)/PP)/NP 	 2 	 in left
30 	 29 	 PP/NP 	 1 	 doubt in
<\s>
<s id="wsj_0552.3"> 14
0 	 1 	 ((S[dcl]\NP[expl])/S[em])/PP 	 1 	 It was
1 	 2 	 (S\NP)\(S\NP) 	 2 	 was n't
3 	 1 	 ((S[dcl]\NP[expl])/S[em])/PP 	 3 	 until was
6 	 3 	 PP/NP 	 1 	 1980s until
6 	 4 	 NP[nb]/N 	 1 	 1980s the
6 	 5 	 N/N 	 1 	 1980s early
7 	 1 	 ((S[dcl]\NP[expl])/S[em])/PP 	 2 	 that was
8 	 9 	 ((S[dcl]\NP)/(S[adj]\NP))/NP 	 1 	 Akzo nursed
9 	 7 	 S[em]/S[dcl] 	 1 	 nursed that
10 	 9 	 ((S[dcl]\NP)/(S[adj]\NP))/NP 	 3 	 itself nursed
10 	 11 	 (S[adj]\NP)/PP 	 1 	 itself back <XB>
11 	 9 	 ((S[dcl]\NP)/(S[adj]\NP))/NP 	 2 	 back nursed
12 	 11 	 (S[adj]\NP)/PP 	 2 	 to back
13 	 12 	 PP/NP 	 1 	 health to
<\s>
<s id="wsj_0552.4"> 22
5 	 3 	 NP[nb]/N 	 1 	 downturn a
5 	 4 	 N/N 	 1 	 downturn new
5 	 6 	 (NP\NP)/NP 	 1 	 downturn in
5 	 10 	 S[dcl]\NP 	 1 	 downturn looms
9 	 6 	 (NP\NP)/NP 	 2 	 industry in
9 	 7 	 NP[nb]/N 	 1 	 industry the
9 	 8 	 N/N 	 1 	 industry chemical
10 	 2 	 (S/S)/S[dcl] 	 2 	 looms as
12 	 13 	 (S[dcl]\NP)/S[dcl] 	 1 	 Akzo says
13 	 0 	 S/S 	 1 	 says Now
13 	 2 	 (S/S)/S[dcl] 	 1 	 says as
14 	 15 	 (S[dcl]\NP)/PP 	 1 	 it is
15 	 13 	 (S[dcl]\NP)/S[dcl] 	 2 	 is says
16 	 15 	 (S[dcl]\NP)/PP 	 2 	 in is
18 	 17 	 (N/N)/(N/N) 	 2 	 better far
19 	 16 	 PP/NP 	 1 	 shape in
19 	 18 	 N/N 	 1 	 shape better
21 	 20 	 (S[to]\NP)/(S[b]\NP) 	 2 	 cope to
<\s>
<s id="wsj_0552.5"> 4
1 	 0 	 N/N 	 1 	 analysts Investment
1 	 3 	 S[dcl]\NP 	 1 	 analysts agree
3 	 2 	 (S\NP)/(S\NP) 	 2 	 agree generally
<\s>
<s id="wsj_0552.6"> 31
1 	 0 	 (S/S)/PP 	 2 	 from Aside
2 	 1 	 PP/(S[ng]\NP) 	 1 	 slashing from
3 	 2 	 (S[ng]\NP)/NP 	 2 	 costs slashing
5 	 1 	 PP/(S[ng]\NP) 	 1 	 investing from
5 	 6 	 (S\NP)\(S\NP) 	 2 	 investing heavily
7 	 5 	 (S[ng]\NP)/PP 	 2 	 in investing
9 	 7 	 PP/NP 	 1 	 plants in
9 	 8 	 NP[nb]/N 	 1 	 plants its
11 	 12 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 Akzo has
11 	 13 	 ((S[pt]\NP)/PP)/NP 	 1 	 Akzo spent <XB>
11 	 27 	 ((S[b]\NP)/NP)/NP 	 1 	 Akzo give <XB>
12 	 0 	 (S/S)/PP 	 1 	 has Aside
13 	 12 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 spent has
13 	 24 	 ((S\NP)\(S\NP))/NP 	 2 	 spent since
15 	 14 	 (N/N)/(N/N) 	 2 	 billion 3.9
16 	 13 	 ((S[pt]\NP)/PP)/NP 	 3 	 guilders spent
16 	 15 	 N/N 	 1 	 guilders billion
16 	 17 	 (NP\NP)/NP 	 1 	 guilders -LRB-
18 	 17 	 (NP\NP)/NP 	 2 	 $ -LRB-
20 	 18 	 N/N[num] 	 1 	 billion $
20 	 19 	 N/N 	 1 	 billion 1.88
22 	 13 	 ((S[pt]\NP)/PP)/NP 	 2 	 on spent
23 	 22 	 PP/NP 	 1 	 acquisitions on
25 	 24 	 ((S\NP)\(S\NP))/NP 	 3 	 1983 since
27 	 26 	 (S[to]\NP)/(S[b]\NP) 	 2 	 give to
28 	 27 	 ((S[b]\NP)/NP)/NP 	 3 	 it give
30 	 27 	 ((S[b]\NP)/NP)/NP 	 2 	 balance give
30 	 29 	 N/N 	 1 	 balance better
<\s>
<s id="wsj_0552.7"> 15
3 	 0 	 (S/S)/NP 	 2 	 period During
3 	 1 	 NP[nb]/N 	 1 	 period the
3 	 2 	 N/N 	 1 	 period same
6 	 5 	 NP[nb]/N 	 1 	 company the
6 	 7 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 company has
6 	 8 	 (S[pt]\NP)/NP 	 1 	 company sold <XB>
7 	 0 	 (S/S)/NP 	 1 	 has During
8 	 7 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 sold has
11 	 9 	 (N/N)/(N/N) 	 2 	 billion about
11 	 10 	 (N/N)/(N/N) 	 2 	 billion 1.6
12 	 8 	 (S[pt]\NP)/NP 	 2 	 guilders sold
12 	 11 	 N/N 	 1 	 guilders billion
12 	 13 	 (NP\NP)/NP 	 1 	 guilders of
14 	 13 	 (NP\NP)/NP 	 2 	 assets of
<\s>
<s id="wsj_0552.8"> 26
2 	 0 	 NP[nb]/N 	 1 	 business The
2 	 1 	 N/N 	 1 	 business fibers
2 	 4 	 ((NP\NP)/(S[dcl]\NP))/N 	 1 	 business whose
2 	 17 	 (S[dcl]\NP)/PP 	 1 	 business accounts
5 	 4 	 ((NP\NP)/(S[dcl]\NP))/N 	 3 	 products whose
5 	 6 	 (S[dcl]\NP)/PP 	 1 	 products go <XB>
6 	 4 	 ((NP\NP)/(S[dcl]\NP))/N 	 2 	 go whose
7 	 6 	 (S[dcl]\NP)/PP 	 2 	 into go
8 	 7 	 PP/NP 	 1 	 textiles into
10 	 7 	 PP/NP 	 1 	 carpeting into
14 	 7 	 PP/NP 	 1 	 uses into
14 	 12 	 N/N 	 1 	 uses myriad
14 	 13 	 N/N 	 1 	 uses industrial
17 	 16 	 (S\NP)/(S\NP) 	 2 	 accounts now
18 	 17 	 (S[dcl]\NP)/PP 	 2 	 for accounts
20 	 19 	 (N/N)/(N/N) 	 2 	 20 only
21 	 18 	 PP/NP 	 1 	 % for
21 	 20 	 N/N 	 1 	 % 20
21 	 22 	 (NP\NP)/NP 	 1 	 % of
23 	 24 	 (NP[nb]/N)\NP 	 2 	 Akzo 's
25 	 22 	 (NP\NP)/NP 	 2 	 sales of
25 	 24 	 (NP[nb]/N)\NP 	 1 	 sales 's
<\s>
<s id="wsj_0552.9"> 18
0 	 1 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 We have
0 	 3 	 (S[pt]\NP)/(S[adj]\NP) 	 1 	 We become <XB>
0 	 5 	 S[adj]\NP 	 1 	 We cyclical <XB>
1 	 2 	 (S\NP)\(S\NP) 	 2 	 have definitely
1 	 14 	 (S[dcl]\S[dcl])\NP 	 1 	 have said
3 	 1 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 become have
5 	 3 	 (S[pt]\NP)/(S[adj]\NP) 	 2 	 cyclical become
5 	 4 	 (S[adj]\NP)/(S[adj]\NP) 	 2 	 cyclical less
8 	 7 	 N/N 	 1 	 Bergsma Syb
8 	 14 	 (S[dcl]\S[dcl])\NP 	 2 	 Bergsma said
12 	 10 	 N/N 	 1 	 president-finance executive
12 	 11 	 N/N 	 1 	 president-finance vice
12 	 14 	 (S[dcl]\S[dcl])\NP 	 2 	 president-finance said
14 	 15 	 (S\S)/NP 	 1 	 said in
17 	 15 	 (S\S)/NP 	 2 	 interview in
17 	 16 	 NP[nb]/N 	 1 	 interview an
<\s>
<s id="wsj_0552.10"> 24
2 	 3 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 Akzo has
2 	 6 	 (S[pt]\NP)/NP 	 1 	 Akzo found <XB>
3 	 0 	 S/S 	 1 	 has Still
3 	 4 	 (S\NP)\(S\NP) 	 2 	 has n't
3 	 5 	 (S\NP)\(S\NP) 	 2 	 has yet
6 	 3 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 found has
8 	 6 	 (S[pt]\NP)/NP 	 2 	 way found
8 	 7 	 NP[nb]/N 	 1 	 way a
10 	 9 	 (S[to]\NP)/(S[b]\NP) 	 2 	 achieve to
12 	 10 	 (S[b]\NP)/NP 	 2 	 goal achieve
12 	 11 	 NP[nb]/N 	 1 	 goal another
12 	 13 	 (NP\NP)/NP 	 1 	 goal :
16 	 13 	 (NP\NP)/NP 	 2 	 presence :
16 	 14 	 NP[nb]/N 	 1 	 presence a
16 	 15 	 N/N 	 1 	 presence large
16 	 17 	 (NP\NP)/NP 	 1 	 presence in
20 	 17 	 (NP\NP)/NP 	 2 	 market in
20 	 18 	 NP[nb]/N 	 1 	 market the
20 	 19 	 N/N 	 1 	 market U.S.
20 	 21 	 (NP\NP)/NP 	 1 	 market for
23 	 21 	 (NP\NP)/NP 	 2 	 drugs for
23 	 22 	 N/N 	 1 	 drugs prescription
<\s>
<s id="wsj_0552.11"> 25
1 	 0 	 N/N 	 1 	 Bergsma Mr.
1 	 2 	 (S[dcl]\NP)/S[dcl] 	 1 	 Bergsma said
3 	 4 	 (NP\NP)/NP 	 1 	 prices for
3 	 8 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 prices remain
3 	 10 	 S[adj]\NP 	 1 	 prices high <XB>
3 	 12 	 (((S[ng]\NP)/S[em])/(S[adj]\NP))/NP[expl] 	 1 	 prices making <XB>
7 	 4 	 (NP\NP)/NP 	 2 	 companies for
7 	 5 	 N/N 	 1 	 companies U.S.
7 	 6 	 N/N 	 1 	 companies pharmaceutical
8 	 2 	 (S[dcl]\NP)/S[dcl] 	 2 	 remain said
10 	 8 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 high remain
10 	 9 	 (S[adj]\NP)/(S[adj]\NP) 	 2 	 high too
13 	 12 	 (((S[ng]\NP)/S[em])/(S[adj]\NP))/NP[expl] 	 4 	 it making
14 	 12 	 (((S[ng]\NP)/S[em])/(S[adj]\NP))/NP[expl] 	 3 	 unlikely making
15 	 12 	 (((S[ng]\NP)/S[em])/(S[adj]\NP))/NP[expl] 	 2 	 that making
16 	 17 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 Akzo will
16 	 18 	 (S[b]\NP)/NP 	 1 	 Akzo pursue <XB>
17 	 15 	 S[em]/S[dcl] 	 1 	 will that
18 	 17 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 pursue will
18 	 22 	 ((S\NP)\(S\NP))/NP 	 2 	 pursue in
21 	 18 	 (S[b]\NP)/NP 	 2 	 acquisitions pursue
21 	 19 	 NP[nb]/N 	 1 	 acquisitions any
21 	 20 	 N/N 	 1 	 acquisitions major
24 	 22 	 ((S\NP)\(S\NP))/NP 	 3 	 area in
24 	 23 	 NP[nb]/N 	 1 	 area that
<\s>
<s id="wsj_0552.12"> 17
1 	 2 	 (S[dcl]\NP)/S[dcl] 	 1 	 he said
2 	 0 	 S/S 	 1 	 said But
2 	 12 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 said although
3 	 4 	 (S[dcl]\NP)/(S[ng]\NP) 	 1 	 Akzo is
3 	 5 	 (S[ng]\NP)/NP 	 1 	 Akzo considering <XB>
4 	 2 	 (S[dcl]\NP)/S[dcl] 	 2 	 is said
5 	 4 	 (S[dcl]\NP)/(S[ng]\NP) 	 2 	 considering is
6 	 5 	 (S[ng]\NP)/NP 	 2 	 alliances considering
6 	 7 	 (NP\NP)/NP 	 1 	 alliances with
10 	 7 	 (NP\NP)/NP 	 2 	 companies with
10 	 8 	 N/N 	 1 	 companies American
10 	 9 	 N/N 	 1 	 companies drug
13 	 14 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 he would
13 	 16 	 S[b]\NP 	 1 	 he elaborate <XB>
14 	 12 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 would although
14 	 15 	 (S\NP)\(S\NP) 	 2 	 would n't
16 	 14 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 elaborate would
<\s>
<s id="wsj_0552.13"> 17
1 	 0 	 NP[nb]/N 	 1 	 indication An
1 	 2 	 (NP\NP)/NP 	 1 	 indication of
1 	 9 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 indication will
1 	 10 	 S[b]\NP 	 1 	 indication come <XB>
3 	 4 	 (NP[nb]/N)\NP 	 2 	 Akzo 's
5 	 2 	 (NP\NP)/NP 	 2 	 success of
5 	 4 	 (NP[nb]/N)\NP 	 1 	 success 's
5 	 6 	 (NP\NP)/(S[ng]\NP) 	 1 	 success in
7 	 6 	 (NP\NP)/(S[ng]\NP) 	 2 	 reshaping in
8 	 7 	 (S[ng]\NP)/NP 	 2 	 itself reshaping
10 	 9 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 come will
10 	 11 	 (S\NP)\(S\NP) 	 2 	 come Thursday
10 	 12 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 come when
13 	 14 	 (S[dcl]\NP)/NP 	 1 	 it reports
14 	 12 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 reports when
16 	 14 	 (S[dcl]\NP)/NP 	 2 	 results reports
16 	 15 	 N/N 	 1 	 results third-quarter
<\s>
<s id="wsj_0552.14"> 23
0 	 1 	 ((S[dcl]\NP)/(S[to]\NP))/NP 	 1 	 Analysts expect
3 	 1 	 ((S[dcl]\NP)/(S[to]\NP))/NP 	 3 	 company expect
3 	 2 	 NP[nb]/N 	 1 	 company the
3 	 5 	 (S[b]\NP)/NP 	 1 	 company show <XB>
4 	 1 	 ((S[dcl]\NP)/(S[to]\NP))/NP 	 2 	 to expect
5 	 4 	 (S[to]\NP)/(S[b]\NP) 	 2 	 show to
6 	 5 	 (S[b]\NP)/NP 	 2 	 profit show
6 	 7 	 (NP\NP)/NP 	 1 	 profit of
10 	 8 	 (N/N)/(N/N) 	 2 	 million about
10 	 9 	 (N/N)/(N/N) 	 2 	 million 225
11 	 7 	 (NP\NP)/NP 	 2 	 guilders of
11 	 10 	 N/N 	 1 	 guilders million
11 	 13 	 ((NP\NP)/PP)/NP 	 1 	 guilders up
15 	 13 	 ((NP\NP)/PP)/NP 	 3 	 % up
15 	 14 	 N/N 	 1 	 % 9
16 	 13 	 ((NP\NP)/PP)/NP 	 2 	 from up
16 	 22 	 (PP\PP)\NP 	 1 	 from earlier
18 	 17 	 (N/N)/(N/N) 	 2 	 million 206.3
19 	 16 	 PP/NP 	 1 	 guilders from
19 	 18 	 N/N 	 1 	 guilders million
21 	 20 	 NP[nb]/N 	 1 	 year a
21 	 22 	 (PP\PP)\NP 	 2 	 year earlier
<\s>
<s id="wsj_0552.15"> 20
2 	 0 	 NP[nb]/N 	 1 	 test A
2 	 1 	 N/N 	 1 	 test bigger
2 	 3 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 test will
2 	 4 	 S[b]\NP 	 1 	 test come <XB>
4 	 3 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 come will
4 	 6 	 (S\NP)\(S\NP) 	 2 	 come year
4 	 7 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 come if
6 	 5 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 year next
11 	 10 	 N/N 	 1 	 analysts many
11 	 12 	 S[dcl]\NP 	 1 	 analysts expect
12 	 9 	 (S/S)/S[dcl] 	 2 	 expect as
16 	 14 	 N/N 	 1 	 prices bulk
16 	 15 	 N/N 	 1 	 prices chemical
16 	 17 	 S[dcl]\NP 	 1 	 prices slump
17 	 7 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 slump if
17 	 9 	 (S/S)/S[dcl] 	 1 	 slump as
17 	 18 	 ((S\NP)\(S\NP))/NP 	 2 	 slump in
19 	 18 	 ((S\NP)\(S\NP))/NP 	 3 	 Europe in
<\s>
<s id="wsj_0552.16"> 20
1 	 2 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 Akzo can
1 	 3 	 (S[b]\NP)/NP 	 1 	 Akzo surprise <XB>
2 	 0 	 S/S 	 1 	 can Maybe
2 	 10 	 (S[dcl]\S[dcl])/NP 	 1 	 can said
3 	 2 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 surprise can
3 	 7 	 ((S\NP)\(S\NP))/N 	 2 	 surprise a
6 	 3 	 (S[b]\NP)/NP 	 2 	 world surprise
6 	 4 	 NP[nb]/N 	 1 	 world the
6 	 5 	 N/N 	 1 	 world investment
8 	 7 	 ((S\NP)\(S\NP))/N 	 3 	 bit a
12 	 10 	 (S[dcl]\S[dcl])/NP 	 2 	 Visker said
12 	 11 	 N/N 	 1 	 Visker Jaap
15 	 10 	 (S[dcl]\S[dcl])/NP 	 2 	 analyst said
15 	 14 	 NP[nb]/N 	 1 	 analyst an
15 	 16 	 (NP\NP)/NP 	 1 	 analyst at
19 	 16 	 (NP\NP)/NP 	 2 	 NV at
19 	 17 	 N/N 	 1 	 NV Amsterdam-Rotterdam
19 	 18 	 N/N 	 1 	 NV Bank
<\s>
<s id="wsj_0552.17"> 20
0 	 1 	 (S[dcl]\NP)/S[dcl] 	 1 	 He figures
2 	 3 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 Akzo is
2 	 4 	 (S[adj]\NP)/(S[to]\NP) 	 1 	 Akzo likely <XB>
3 	 1 	 (S[dcl]\NP)/S[dcl] 	 2 	 is figures
4 	 3 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 likely is
5 	 4 	 (S[adj]\NP)/(S[to]\NP) 	 2 	 to likely
6 	 5 	 (S[to]\NP)/(S[b]\NP) 	 2 	 be to
7 	 6 	 (S[b]\NP)/NP 	 2 	 one be
7 	 8 	 (NP\NP)/NP 	 1 	 one of
13 	 8 	 (NP\NP)/NP 	 2 	 companies of
13 	 9 	 NP[nb]/N 	 1 	 companies the
13 	 10 	 N/N 	 1 	 companies few
13 	 11 	 N/N 	 1 	 companies major
13 	 12 	 N/N 	 1 	 companies chemical
15 	 14 	 (S[to]\NP)/(S[b]\NP) 	 2 	 show to
15 	 19 	 (S\NP)\(S\NP) 	 2 	 show year
17 	 15 	 (S[b]\NP)/NP 	 2 	 growth show
17 	 16 	 N/N 	 1 	 growth profit
19 	 18 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 year next
<\s>
<s id="wsj_0552.18"> 30
1 	 0 	 NP[nb]/N 	 1 	 bank The
1 	 2 	 (S[dcl]\NP)/S[dcl] 	 1 	 bank projects
3 	 4 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 Akzo will
3 	 5 	 (S[b]\NP)/NP 	 1 	 Akzo show <XB>
4 	 2 	 (S[dcl]\NP)/S[dcl] 	 2 	 will projects
5 	 4 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 show will
5 	 11 	 ((S\NP)\(S\NP))/NP 	 2 	 show in
5 	 14 	 ((S\NP)\(S\NP))/PP 	 2 	 show up
7 	 5 	 (S[b]\NP)/NP 	 2 	 earnings show
7 	 6 	 N/N 	 1 	 earnings per-share
7 	 8 	 (NP\NP)/NP 	 1 	 earnings of
10 	 8 	 (NP\NP)/NP 	 2 	 guilders of
10 	 9 	 N/N 	 1 	 guilders 24
12 	 11 	 ((S\NP)\(S\NP))/NP 	 3 	 1990 in
15 	 14 	 ((S\NP)\(S\NP))/PP 	 3 	 from up
19 	 15 	 PP/NP 	 1 	 guilders from
19 	 16 	 NP[nb]/N 	 1 	 guilders an
19 	 17 	 N/N 	 1 	 guilders estimated
19 	 18 	 N/N 	 1 	 guilders 22.5
19 	 20 	 (NP\NP)/NP 	 1 	 guilders for
22 	 20 	 (NP\NP)/NP 	 2 	 year for
22 	 21 	 NP[nb]/N 	 1 	 year this
26 	 15 	 PP/NP 	 1 	 guilders from
26 	 24 	 NP[nb]/N 	 1 	 guilders the
26 	 25 	 N/N 	 1 	 guilders 20.9
26 	 27 	 (S[pss]\NP)/PP 	 1 	 guilders reported <XB>
28 	 27 	 (S[pss]\NP)/PP 	 2 	 for reported
29 	 28 	 PP/NP 	 1 	 1988 for
<\s>
<s id="wsj_0552.19"> 28
4 	 0 	 (S/S)/NP 	 2 	 Co. At
4 	 1 	 N/N 	 1 	 Co. James
4 	 2 	 N/N 	 1 	 Co. Capel
4 	 3 	 N/N 	 1 	 Co. &
4 	 5 	 (NP\NP)/NP 	 1 	 Co. in
6 	 5 	 (NP\NP)/NP 	 2 	 London in
10 	 8 	 N/N 	 1 	 Ashurst analyst
10 	 9 	 N/N 	 1 	 Ashurst Jackie
10 	 11 	 (S[dcl]\NP)/S[em] 	 1 	 Ashurst notes
11 	 0 	 (S/S)/NP 	 1 	 notes At
12 	 11 	 (S[dcl]\NP)/S[em] 	 2 	 that notes
13 	 14 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 Akzo is
13 	 16 	 S[adj]\NP 	 1 	 Akzo exposed <XB>
14 	 12 	 S[em]/S[dcl] 	 1 	 is that
16 	 14 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 exposed is
16 	 15 	 (S[adj]\NP)/(S[adj]\NP) 	 2 	 exposed less
16 	 17 	 ((S[adj]\NP)\(S[adj]\NP))/NP 	 2 	 exposed than
16 	 22 	 ((S[adj]\NP)\(S[adj]\NP))/NP 	 2 	 exposed to
18 	 17 	 ((S[adj]\NP)\(S[adj]\NP))/NP 	 3 	 many than
18 	 19 	 (NP\NP)/NP 	 1 	 many of
21 	 19 	 (NP\NP)/NP 	 2 	 rivals of
21 	 20 	 NP[nb]/N 	 1 	 rivals its
25 	 24 	 (N/N)/(N/N) 	 2 	 volatile most
27 	 22 	 ((S[adj]\NP)\(S[adj]\NP))/NP 	 3 	 products to
27 	 23 	 NP[nb]/N 	 1 	 products the
27 	 25 	 N/N 	 1 	 products volatile
27 	 26 	 N/N 	 1 	 products chemical
<\s>
<s id="wsj_0552.20"> 19
1 	 0 	 (S/S)/NP 	 2 	 example For
3 	 4 	 (S[dcl]\NP)/NP 	 1 	 Akzo has
3 	 10 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 Akzo is <XU>
3 	 11 	 S[adj]\NP 	 1 	 Akzo small <XU>
3 	 15 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 Akzo does <XU>
3 	 17 	 (S[b]\NP)/NP 	 1 	 Akzo make <XU>
4 	 0 	 (S/S)/NP 	 1 	 has For
4 	 5 	 (S\NP)\(S\NP) 	 2 	 has only
8 	 4 	 (S[dcl]\NP)/NP 	 2 	 operations has
8 	 6 	 N/N 	 1 	 operations minor
8 	 7 	 N/N 	 1 	 operations petrochemical
10 	 0 	 (S/S)/NP 	 1 	 is For
10 	 12 	 ((S\NP)\(S\NP))/NP 	 2 	 is in
11 	 10 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 small is
13 	 12 	 ((S\NP)\(S\NP))/NP 	 3 	 plastics in
15 	 0 	 (S/S)/NP 	 1 	 does For
15 	 16 	 (S\NP)\(S\NP) 	 2 	 does n't
17 	 15 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 make does
18 	 17 	 (S[b]\NP)/NP 	 2 	 fertilizers make
<\s>
<s id="wsj_0552.21"> 29
3 	 4 	 (S[dcl]\NP)/PP 	 1 	 Akzo profited
4 	 2 	 (S/S)/S[dcl] 	 2 	 profited while
4 	 5 	 (S\NP)\(S\NP) 	 2 	 profited less
5 	 6 	 (((S\NP)\(S\NP))\((S\NP)\(S\NP)))/NP 	 3 	 less than
8 	 6 	 (((S\NP)\(S\NP))\((S\NP)\(S\NP)))/NP 	 4 	 rivals than
8 	 7 	 N/N 	 1 	 rivals many
9 	 4 	 (S[dcl]\NP)/PP 	 2 	 from profited
11 	 9 	 PP/NP 	 1 	 boom from
11 	 10 	 NP[nb]/N 	 1 	 boom the
11 	 12 	 (NP\NP)/NP 	 1 	 boom of
11 	 15 	 (NP\NP)/NP 	 1 	 boom in
14 	 12 	 (NP\NP)/NP 	 2 	 years of
14 	 13 	 N/N 	 1 	 years recent
16 	 15 	 (NP\NP)/NP 	 2 	 petrochemicals in
18 	 15 	 (NP\NP)/NP 	 2 	 plastics in
20 	 21 	 (S[dcl]\NP)/NP 	 1 	 it has
21 	 0 	 S/S 	 1 	 has Thus
21 	 2 	 (S/S)/S[dcl] 	 1 	 has while
22 	 21 	 (S[dcl]\NP)/NP 	 2 	 less has
22 	 24 	 (S[b]\NP)/NP 	 2 	 less fear <XU>
24 	 23 	 (S[to]\NP)/(S[b]\NP) 	 2 	 fear to
24 	 25 	 ((S\NP)\(S\NP))/NP 	 2 	 fear from
28 	 25 	 ((S\NP)\(S\NP))/NP 	 3 	 slump from
28 	 26 	 NP[nb]/N 	 1 	 slump the
28 	 27 	 N/N 	 1 	 slump current
<\s>
<s id="wsj_0552.22"> 9
1 	 0 	 NP[nb]/N 	 1 	 company The
1 	 2 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 company is
1 	 3 	 (S[pss]\NP)/PP 	 1 	 company exposed <XB>
3 	 2 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 exposed is
3 	 8 	 (S\NP)\(S\NP) 	 2 	 exposed however
4 	 3 	 (S[pss]\NP)/PP 	 2 	 to exposed
6 	 4 	 PP/NP 	 1 	 chemicals to
6 	 5 	 N/N 	 1 	 chemicals bulk
<\s>
<s id="wsj_0552.23"> 20
2 	 1 	 N/N 	 1 	 prices bulk-chemical
2 	 3 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 prices have
2 	 4 	 (S[pt]\NP)/(S[ng]\NP) 	 1 	 prices begun <XB>
2 	 5 	 S[ng]\NP 	 1 	 prices falling <XB>
3 	 0 	 (S/S)/S[dcl] 	 2 	 have Although
4 	 3 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 begun have
4 	 6 	 ((S\NP)\(S\NP))/NP 	 2 	 begun in
5 	 4 	 (S[pt]\NP)/(S[ng]\NP) 	 2 	 falling begun
8 	 6 	 ((S\NP)\(S\NP))/NP 	 3 	 U.S. in
8 	 7 	 NP[nb]/N 	 1 	 U.S. the
10 	 11 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 they are
10 	 13 	 S[adj]\NP 	 1 	 they stable <XB>
11 	 0 	 (S/S)/S[dcl] 	 1 	 are Although
11 	 12 	 (S\NP)\(S\NP) 	 2 	 are generally
11 	 14 	 ((S\NP)\(S\NP))/NP 	 2 	 are in
11 	 19 	 (S[dcl]\S[dcl])\NP 	 1 	 are said
13 	 11 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 stable are
15 	 14 	 ((S\NP)\(S\NP))/NP 	 3 	 Europe in
18 	 17 	 N/N 	 1 	 Bergsma Mr.
18 	 19 	 (S[dcl]\S[dcl])\NP 	 2 	 Bergsma said
<\s>
<s id="wsj_0552.24"> 27
1 	 0 	 NP[nb]/N 	 1 	 decline A
1 	 2 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 decline may
1 	 3 	 S[b]\NP 	 1 	 decline come <XB>
2 	 12 	 (S[dcl]\NP)/S[dcl] 	 2 	 may said <XU>
3 	 2 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 come may
3 	 4 	 ((S\NP)\(S\NP))/NP 	 2 	 come in
7 	 4 	 ((S\NP)\(S\NP))/NP 	 3 	 half in
7 	 5 	 NP[nb]/N 	 1 	 half the
7 	 6 	 N/N 	 1 	 half first
7 	 8 	 (NP\NP)/NP 	 1 	 half of
9 	 8 	 (NP\NP)/NP 	 2 	 1990 of
11 	 12 	 (S[dcl]\NP)/S[dcl] 	 1 	 he said
16 	 15 	 NP[nb]/N 	 1 	 market the
16 	 17 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 market does
16 	 19 	 (S[b]\NP)/PP 	 1 	 market appear <XB>
17 	 18 	 (S\NP)\(S\NP) 	 2 	 does n't
19 	 17 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 appear does
20 	 19 	 (S[b]\NP)/PP 	 2 	 on appear
22 	 20 	 PP/NP 	 1 	 verge on
22 	 21 	 NP[nb]/N 	 1 	 verge the
22 	 23 	 (NP\NP)/NP 	 1 	 verge of
26 	 23 	 (NP\NP)/NP 	 2 	 downturn of
26 	 24 	 NP[nb]/N 	 1 	 downturn a
26 	 25 	 N/N 	 1 	 downturn severe
<\s>
<s id="wsj_0552.25"> 35
1 	 0 	 (S[to]\NP)/(S[b]\NP) 	 2 	 reduce To
3 	 1 	 (S[b]\NP)/NP 	 2 	 danger reduce
3 	 2 	 NP[nb]/N 	 1 	 danger the
3 	 4 	 (NP\NP)/NP 	 1 	 danger of
7 	 4 	 (NP\NP)/NP 	 2 	 cycles of
7 	 5 	 NP/NP 	 1 	 cycles such
7 	 6 	 N/N 	 1 	 cycles pricing
9 	 10 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 Akzo has
9 	 11 	 (S[pt]\NP)/PP 	 1 	 Akzo invested <XB>
11 	 10 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 invested has
11 	 12 	 (S\NP)\(S\NP) 	 2 	 invested heavily
13 	 11 	 (S[pt]\NP)/PP 	 2 	 in invested
15 	 13 	 PP/NP 	 1 	 chemicals in
15 	 14 	 N/N 	 1 	 chemicals specialty
15 	 17 	 (NP\NP)/(S[dcl]\NP) 	 1 	 chemicals which
15 	 18 	 (S[dcl]\NP)/NP 	 1 	 chemicals have <XB>
15 	 24 	 (S[dcl]\NP)/(S[to]\NP) 	 1 	 chemicals tend <XU>
15 	 26 	 (S[b]\NP)/NP 	 1 	 chemicals produce <XU>
18 	 17 	 (NP\NP)/(S[dcl]\NP) 	 2 	 have which
20 	 19 	 (N/N)/(N/N) 	 2 	 specific highly
22 	 18 	 (S[dcl]\NP)/NP 	 2 	 uses have
22 	 20 	 N/N 	 1 	 uses specific
22 	 21 	 N/N 	 1 	 uses industrial
24 	 17 	 (NP\NP)/(S[dcl]\NP) 	 2 	 tend which
25 	 24 	 (S[dcl]\NP)/(S[to]\NP) 	 2 	 to tend
26 	 25 	 (S[to]\NP)/(S[b]\NP) 	 2 	 produce to
27 	 28 	 (N/N)\(N/N) 	 2 	 much higher
30 	 26 	 (S[b]\NP)/NP 	 2 	 margins produce
30 	 27 	 N/N 	 1 	 margins much
30 	 29 	 N/N 	 1 	 margins profit
30 	 31 	 (NP\NP)/S[inv] 	 1 	 margins than
32 	 31 	 (NP\NP)/S[inv] 	 2 	 do than
34 	 32 	 S[inv]/NP 	 1 	 chemicals do
34 	 33 	 N/N 	 1 	 chemicals bulk
<\s>
<s id="wsj_0552.26"> 23
0 	 1 	 (NP[nb]/N)\NP 	 2 	 Akzo 's
3 	 1 	 (NP[nb]/N)\NP 	 1 	 move 's
3 	 2 	 N/N 	 1 	 move biggest
3 	 4 	 (NP\NP)/NP 	 1 	 move in
3 	 7 	 (S[dcl]\NP)/NP 	 1 	 move was
6 	 4 	 (NP\NP)/NP 	 2 	 area in
6 	 5 	 NP[nb]/N 	 1 	 area this
10 	 7 	 (S[dcl]\NP)/NP 	 2 	 acquisition was
10 	 8 	 NP[nb]/N 	 1 	 acquisition the
10 	 9 	 N/N 	 1 	 acquisition 1987
10 	 11 	 (NP\NP)/NP 	 1 	 acquisition of
10 	 19 	 (NP\NP)/NP 	 1 	 acquisition for
14 	 12 	 N/N 	 1 	 Co. Stauffer
14 	 13 	 N/N 	 1 	 Co. Chemical
14 	 15 	 (NP[nb]/N)\NP 	 2 	 Co. 's
18 	 11 	 (NP\NP)/NP 	 2 	 business of
18 	 15 	 (NP[nb]/N)\NP 	 1 	 business 's
18 	 16 	 N/N 	 1 	 business specialty
18 	 17 	 N/N 	 1 	 business chemical
20 	 19 	 (NP\NP)/NP 	 2 	 $ for
22 	 20 	 N/N[num] 	 1 	 million $
22 	 21 	 N/N 	 1 	 million 625
<\s>
<s id="wsj_0552.27"> 35
3 	 2 	 (N/N)/(N/N) 	 2 	 glamorous less
4 	 0 	 (S/S)/NP 	 2 	 field In
4 	 1 	 NP[nb]/N 	 1 	 field a
4 	 3 	 N/N 	 1 	 field glamorous
6 	 7 	 (S[dcl]\NP)/NP 	 1 	 Akzo is
7 	 0 	 (S/S)/NP 	 1 	 is In
9 	 8 	 NP[nb]/N 	 1 	 world the
9 	 10 	 (NP[nb]/N)\NP 	 2 	 world 's
12 	 7 	 (S[dcl]\NP)/NP 	 2 	 producer is
12 	 10 	 (NP[nb]/N)\NP 	 1 	 producer 's
12 	 11 	 N/N 	 1 	 producer biggest
12 	 13 	 (NP\NP)/NP 	 1 	 producer of
15 	 13 	 (NP\NP)/NP 	 2 	 salt of
15 	 14 	 N/N 	 1 	 salt industrial
15 	 17 	 (S[pss]\NP)/PP 	 1 	 salt used <XB>
18 	 17 	 (S[pss]\NP)/PP 	 2 	 as used
21 	 18 	 PP/NP 	 1 	 material as
21 	 19 	 NP[nb]/N 	 1 	 material a
21 	 20 	 N/N 	 1 	 material raw
21 	 22 	 (NP\NP)/NP 	 1 	 material for
25 	 22 	 (NP\NP)/NP 	 2 	 industry for
25 	 23 	 NP[nb]/N 	 1 	 industry the
25 	 24 	 N/N 	 1 	 industry chemical
28 	 26 	 conj/conj 	 1 	 as as
28 	 27 	 conj/conj 	 1 	 as well
29 	 17 	 (S[pss]\NP)/PP 	 2 	 for used
31 	 29 	 PP/NP 	 1 	 tasks for
31 	 30 	 NP/NP 	 1 	 tasks such
31 	 32 	 (NP\NP)/(S[ng]\NP) 	 1 	 tasks as
33 	 32 	 (NP\NP)/(S[ng]\NP) 	 2 	 melting as
34 	 33 	 (S[ng]\NP)/NP 	 2 	 ice melting
<\s>
<s id="wsj_0552.28"> 14
0 	 2 	 (S[dcl]\NP)/NP 	 1 	 Akzo makes
2 	 1 	 (S\NP)/(S\NP) 	 2 	 makes also
3 	 2 	 (S[dcl]\NP)/NP 	 2 	 products makes
3 	 4 	 (S[pss]\NP)/PP 	 1 	 products derived <XB>
3 	 9 	 (NP\NP)/NP 	 1 	 products as
5 	 4 	 (S[pss]\NP)/PP 	 2 	 from derived
6 	 5 	 PP/NP 	 1 	 salt from
9 	 8 	 (NP\NP)/(NP\NP) 	 2 	 as such
10 	 9 	 (NP\NP)/NP 	 2 	 chlorine as
13 	 9 	 (NP\NP)/NP 	 2 	 soda as
13 	 12 	 N/N 	 1 	 soda caustic
<\s>
<s id="wsj_0552.29"> 14
3 	 0 	 (S/S)/NP 	 2 	 division In
3 	 1 	 NP[nb]/N 	 1 	 division the
3 	 2 	 N/N 	 1 	 division fibers
5 	 6 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 profit remains
5 	 7 	 S[adj]\NP 	 1 	 profit weak <XB>
6 	 0 	 (S/S)/NP 	 1 	 remains In
6 	 10 	 ((S\NP)\(S\NP))/PP 	 2 	 remains because
7 	 6 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 weak remains
10 	 9 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 because largely
11 	 10 	 ((S\NP)\(S\NP))/PP 	 3 	 of because
13 	 11 	 PP/NP 	 1 	 overcapacity of
13 	 12 	 N/N 	 1 	 overcapacity persistent
<\s>
<s id="wsj_0552.30"> 23
1 	 2 	 (S[dcl]\NP)/(S[ng]\NP) 	 1 	 Akzo is
1 	 4 	 S[ng]\NP 	 1 	 Akzo slimming <XB>
2 	 0 	 S/S 	 1 	 is But
2 	 3 	 (S\NP)\(S\NP) 	 2 	 is still
2 	 6 	 (S\S)/S[dcl] 	 1 	 is :
4 	 2 	 (S[dcl]\NP)/(S[ng]\NP) 	 2 	 slimming is
4 	 5 	 (S\NP)\(S\NP) 	 2 	 slimming down
7 	 9 	 (S[dcl]\NP)/NP 	 1 	 It announced
9 	 6 	 (S\S)/S[dcl] 	 2 	 announced :
9 	 8 	 (S\NP)/(S\NP) 	 2 	 announced recently
10 	 9 	 (S[dcl]\NP)/NP 	 2 	 plans announced
10 	 12 	 (S[b]\NP)/NP 	 1 	 plans eliminate <XB>
12 	 11 	 (S[to]\NP)/(S[b]\NP) 	 2 	 eliminate to
14 	 13 	 (N/N)/(N/N) 	 2 	 1,700 about
16 	 12 	 (S[b]\NP)/NP 	 2 	 jobs eliminate
16 	 14 	 N/N 	 1 	 jobs 1,700
16 	 15 	 N/N 	 1 	 jobs fiber-related
16 	 17 	 (NP\NP)/NP 	 1 	 jobs in
19 	 17 	 (NP\NP)/NP 	 2 	 Netherlands in
19 	 18 	 NP[nb]/N 	 1 	 Netherlands the
22 	 17 	 (NP\NP)/NP 	 2 	 Germany in
22 	 21 	 N/N 	 1 	 Germany West
<\s>
<s id="wsj_0552.31"> 43
5 	 1 	 NP[nb]/N 	 1 	 markets the
5 	 2 	 N/N 	 1 	 markets polyester
5 	 4 	 N/N 	 1 	 markets rayon
5 	 6 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 markets remain
5 	 8 	 S[adj]\NP 	 1 	 markets bleak <XB>
6 	 0 	 (S/S)/S[dcl] 	 2 	 remain Although
8 	 6 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 bleak remain
8 	 7 	 (S[adj]\NP)/(S[adj]\NP) 	 2 	 bleak mostly
10 	 11 	 (S[dcl]\NP)/NP 	 1 	 Akzo has
11 	 0 	 (S/S)/S[dcl] 	 1 	 has Although
13 	 11 	 (S[dcl]\NP)/NP 	 2 	 hopes has
13 	 12 	 N/N 	 1 	 hopes high
13 	 14 	 (NP\NP)/NP 	 1 	 hopes for
18 	 14 	 (NP\NP)/NP 	 2 	 businesses for
18 	 15 	 NP[nb]/N 	 1 	 businesses some
18 	 16 	 N/N 	 1 	 businesses emerging
18 	 17 	 N/N 	 1 	 businesses fiber
18 	 20 	 (S[adj]\NP)/NP 	 1 	 businesses such <XB>
22 	 20 	 (S[adj]\NP)/NP 	 2 	 fibers such
22 	 21 	 N/N 	 1 	 fibers carbon
24 	 20 	 (S[adj]\NP)/NP 	 2 	 aramid such
27 	 26 	 (N/N)/(N/N) 	 2 	 strong extremely
28 	 20 	 (S[adj]\NP)/NP 	 2 	 fibers such
28 	 27 	 N/N 	 1 	 fibers strong
28 	 29 	 (S[pss]\NP)/(S[to]\NP) 	 1 	 fibers used <XB>
28 	 31 	 (S[b]\NP)/NP 	 1 	 fibers reinforce <XB>
28 	 37 	 (S[b]\NP)/NP 	 1 	 fibers make <XU>
30 	 29 	 (S[pss]\NP)/(S[to]\NP) 	 2 	 to used
31 	 30 	 (S[to]\NP)/(S[b]\NP) 	 2 	 reinforce to
32 	 31 	 (S[b]\NP)/NP 	 2 	 tires reinforce
34 	 31 	 (S[b]\NP)/NP 	 2 	 metals reinforce
36 	 29 	 (S[pss]\NP)/(S[to]\NP) 	 2 	 to used
37 	 36 	 (S[to]\NP)/(S[b]\NP) 	 2 	 make to
39 	 37 	 (S[b]\NP)/NP 	 2 	 products make
39 	 38 	 NP/NP 	 1 	 products such
39 	 40 	 (NP\NP)/NP 	 1 	 products as
42 	 40 	 (NP\NP)/NP 	 2 	 vests as
42 	 41 	 N/N 	 1 	 vests bullet-proof
<\s>
<s id="wsj_0552.32"> 20
0 	 1 	 (NP[nb]/N)\NP 	 2 	 Akzo 's
4 	 1 	 (NP[nb]/N)\NP 	 1 	 fiber 's
4 	 2 	 N/N 	 1 	 fiber Twaron
4 	 3 	 N/N 	 1 	 fiber aramid
4 	 5 	 (S[dcl]\NP)/NP 	 1 	 fiber is
8 	 5 	 (S[dcl]\NP)/NP 	 2 	 second is
8 	 6 	 NP[nb]/N 	 1 	 second a
8 	 7 	 N/N 	 1 	 second distant
8 	 9 	 (NP\NP)/NP 	 1 	 second to
12 	 10 	 N/N 	 1 	 Co. Du
12 	 11 	 N/N 	 1 	 Co. Pont
12 	 13 	 (NP[nb]/N)\NP 	 2 	 Co. 's
14 	 9 	 (NP\NP)/NP 	 2 	 Kevlar to
14 	 13 	 (NP[nb]/N)\NP 	 1 	 Kevlar 's
14 	 16 	 (NP\NP)/(S[dcl]\NP) 	 1 	 Kevlar which
14 	 17 	 (S[dcl]\NP)/NP 	 1 	 Kevlar dominates <XB>
17 	 16 	 (NP\NP)/(S[dcl]\NP) 	 2 	 dominates which
19 	 17 	 (S[dcl]\NP)/NP 	 2 	 market dominates
19 	 18 	 NP[nb]/N 	 1 	 market the
<\s>
<s id="wsj_0552.33"> 19
1 	 0 	 N/N 	 1 	 Bergsma Mr.
1 	 2 	 (S[dcl]\NP)/S[dcl] 	 1 	 Bergsma said
5 	 3 	 N/N 	 1 	 sales world-wide
5 	 4 	 N/N 	 1 	 sales industry
5 	 6 	 (NP\NP)/NP 	 1 	 sales of
5 	 9 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 sales are
5 	 10 	 (S[pss]\NP)/(S[to]\NP) 	 1 	 sales expected <XB>
5 	 12 	 (S[b]\NP)/NP 	 1 	 sales total <XB>
8 	 6 	 (NP\NP)/NP 	 2 	 fibers of
8 	 7 	 N/N 	 1 	 fibers aramid
9 	 2 	 (S[dcl]\NP)/S[dcl] 	 2 	 are said
10 	 9 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 expected are
11 	 10 	 (S[pss]\NP)/(S[to]\NP) 	 2 	 to expected
12 	 11 	 (S[to]\NP)/(S[b]\NP) 	 2 	 total to
12 	 17 	 ((S\NP)\(S\NP))/N 	 2 	 total this
14 	 12 	 (S[b]\NP)/NP 	 2 	 $ total
14 	 13 	 N/N 	 1 	 $ about
16 	 14 	 N/N[num] 	 1 	 million $
16 	 15 	 N/N 	 1 	 million 500
18 	 17 	 ((S\NP)\(S\NP))/N 	 3 	 year this
<\s>
<s id="wsj_0552.34"> 24
1 	 0 	 N/N 	 1 	 growth Sales
1 	 2 	 (NP\NP)/NP 	 1 	 growth of
1 	 7 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 growth seems
1 	 8 	 S[adj]\NP 	 1 	 growth possible <XB>
4 	 2 	 (NP\NP)/NP 	 2 	 % of
4 	 3 	 N/N 	 1 	 % 10
4 	 5 	 (NP\NP)/N 	 1 	 % a
6 	 5 	 (NP\NP)/N 	 2 	 year a
7 	 11 	 (S[dcl]\NP)/S[dcl] 	 2 	 seems said <XU>
8 	 7 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 possible seems
10 	 11 	 (S[dcl]\NP)/S[dcl] 	 1 	 he said
14 	 15 	 ((S[dcl]\NP)/(S[to]\NP))/NP 	 1 	 Akzo expects
18 	 15 	 ((S[dcl]\NP)/(S[to]\NP))/NP 	 3 	 business expects
18 	 16 	 NP[nb]/N 	 1 	 business its
18 	 17 	 N/N 	 1 	 business Twaron
18 	 20 	 (S[b]\NP)/(S[adj]\NP) 	 1 	 business become <XB>
18 	 21 	 S[adj]\NP 	 1 	 business profitable <XB>
19 	 15 	 ((S[dcl]\NP)/(S[to]\NP))/NP 	 2 	 to expects
20 	 19 	 (S[to]\NP)/(S[b]\NP) 	 2 	 become to
20 	 22 	 ((S\NP)\(S\NP))/NP 	 2 	 become in
21 	 20 	 (S[b]\NP)/(S[adj]\NP) 	 2 	 profitable become
23 	 22 	 ((S\NP)\(S\NP))/NP 	 3 	 1990 in
<\s>
<s id="wsj_0552.35"> 15
0 	 2 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 Akzo has
0 	 3 	 (S[pt]\NP)/PP 	 1 	 Akzo spent <XB>
2 	 1 	 (S\NP)/(S\NP) 	 2 	 has also
3 	 2 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 spent has
3 	 4 	 (S\NP)\(S\NP) 	 2 	 spent heavily
5 	 3 	 (S[pt]\NP)/PP 	 2 	 on spent
6 	 5 	 PP/NP 	 1 	 acquisitions on
6 	 7 	 (NP\NP)/NP 	 1 	 acquisitions in
8 	 7 	 (NP\NP)/NP 	 2 	 paints in
11 	 7 	 (NP\NP)/NP 	 2 	 finishes in
11 	 10 	 N/N 	 1 	 finishes auto
14 	 7 	 (NP\NP)/NP 	 2 	 coatings in
14 	 13 	 N/N 	 1 	 coatings industrial
<\s>
<s id="wsj_0552.36"> 34
1 	 0 	 (S/S)/NP 	 2 	 August In
4 	 3 	 (S/S)/NP 	 2 	 example for
6 	 7 	 (S[dcl]\NP)/NP 	 1 	 it completed
7 	 0 	 (S/S)/NP 	 1 	 completed In
7 	 3 	 (S/S)/NP 	 1 	 completed for
11 	 9 	 (N/N)/N[num] 	 2 	 million $
11 	 10 	 N/N 	 1 	 million 110
12 	 7 	 (S[dcl]\NP)/NP 	 2 	 acquisition completed
12 	 8 	 NP[nb]/N 	 1 	 acquisition the
12 	 9 	 (N/N)/N[num] 	 1 	 acquisition $
12 	 13 	 (NP\NP)/NP 	 1 	 acquisition of
12 	 31 	 (NP\NP)/NP 	 1 	 acquisition from
16 	 13 	 (NP\NP)/NP 	 2 	 Inc. of
16 	 14 	 N/N 	 1 	 Inc. Reliance
16 	 15 	 N/N 	 1 	 Inc. Universal
20 	 13 	 (NP\NP)/NP 	 2 	 maker of
20 	 18 	 NP[nb]/N 	 1 	 maker a
20 	 19 	 N/N 	 1 	 maker U.S.
20 	 21 	 (NP\NP)/NP 	 1 	 maker of
23 	 21 	 (NP\NP)/NP 	 2 	 coatings of
23 	 22 	 N/N 	 1 	 coatings industrial
23 	 24 	 (NP\NP)/NP 	 1 	 coatings for
25 	 24 	 (NP\NP)/NP 	 2 	 wood for
27 	 24 	 (NP\NP)/NP 	 2 	 metals for
29 	 24 	 (NP\NP)/NP 	 2 	 plastics for
33 	 31 	 (NP\NP)/NP 	 2 	 Corp from
33 	 32 	 N/N 	 1 	 Corp Tyler
<\s>
<s id="wsj_0552.37"> 25
1 	 0 	 N/N 	 1 	 Bergsma Mr.
1 	 2 	 (S[dcl]\NP)/S[dcl] 	 1 	 Bergsma said
3 	 4 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 Akzo is
3 	 5 	 (S[adj]\NP)/(S[to]\NP) 	 1 	 Akzo likely <XB>
4 	 2 	 (S[dcl]\NP)/S[dcl] 	 2 	 is said
4 	 13 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 is as
5 	 4 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 likely is
6 	 5 	 (S[adj]\NP)/(S[to]\NP) 	 2 	 to likely
7 	 6 	 (S[to]\NP)/(S[b]\NP) 	 2 	 see to
10 	 7 	 (S[b]\NP)/NP 	 2 	 growth see
10 	 8 	 N/N 	 1 	 growth strong
10 	 9 	 N/N 	 1 	 growth profit
10 	 11 	 (NP\NP)/NP 	 1 	 growth from
12 	 11 	 (NP\NP)/NP 	 2 	 coatings from
14 	 15 	 (S[dcl]\NP)/NP 	 1 	 it realizes
15 	 13 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 realizes as
17 	 15 	 (S[dcl]\NP)/NP 	 2 	 savings realizes
17 	 16 	 N/N 	 1 	 savings cost
20 	 15 	 (S[dcl]\NP)/NP 	 2 	 benefits realizes
20 	 19 	 N/N 	 1 	 benefits other
20 	 21 	 (NP\NP)/NP 	 1 	 benefits from
24 	 21 	 (NP\NP)/NP 	 2 	 scale from
24 	 22 	 NP[nb]/N 	 1 	 scale its
24 	 23 	 N/N 	 1 	 scale greater
<\s>
<s id="wsj_0552.38"> 24
1 	 2 	 (NP[nb]/N)\NP 	 2 	 Akzo 's
4 	 0 	 (S/S)/NP 	 2 	 business For
4 	 2 	 (NP[nb]/N)\NP 	 1 	 business 's
4 	 3 	 N/N 	 1 	 business drug
4 	 6 	 (NP\NP)/S[dcl] 	 1 	 business where
7 	 8 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 profits have
7 	 9 	 (S[pt]\NP)/NP 	 1 	 profits shown <XB>
8 	 6 	 (NP\NP)/S[dcl] 	 2 	 have where
9 	 8 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 shown have
9 	 12 	 ((S\NP)\(S\NP))/NP 	 2 	 shown for
11 	 9 	 (S[pt]\NP)/NP 	 2 	 change shown
11 	 10 	 N/N 	 1 	 change litle
16 	 12 	 ((S\NP)\(S\NP))/NP 	 3 	 years for
16 	 13 	 NP[nb]/N 	 1 	 years the
16 	 14 	 N/N 	 1 	 years past
16 	 15 	 N/N 	 1 	 years five
19 	 18 	 N/N 	 1 	 Bergsma Mr.
19 	 20 	 (S[dcl]\NP)/NP 	 1 	 Bergsma predicted
20 	 0 	 (S/S)/NP 	 1 	 predicted For
23 	 20 	 (S[dcl]\NP)/NP 	 2 	 growth predicted
23 	 21 	 N/N 	 1 	 growth moderate
23 	 22 	 N/N 	 1 	 growth profit
<\s>
<s id="wsj_0552.39"> 25
0 	 1 	 (S[dcl]\NP)/NP 	 1 	 Akzo is
0 	 11 	 (S[dcl]\NP)/(S[ng]\NP) 	 1 	 Akzo is <XU>
0 	 13 	 (S[ng]\NP)/NP 	 1 	 Akzo seeking <XU>
1 	 8 	 ((S\NP)\(S\NP))/NP 	 2 	 is in
4 	 1 	 (S[dcl]\NP)/NP 	 2 	 seller is
4 	 2 	 NP[nb]/N 	 1 	 seller the
4 	 3 	 N/N 	 1 	 seller leading
4 	 5 	 (NP\NP)/NP 	 1 	 seller of
7 	 5 	 (NP\NP)/NP 	 2 	 pills of
7 	 6 	 N/N 	 1 	 pills birth-control
9 	 8 	 ((S\NP)\(S\NP))/NP 	 3 	 Europe in
11 	 12 	 (S\NP)\(S\NP) 	 2 	 is still
13 	 11 	 (S[dcl]\NP)/(S[ng]\NP) 	 2 	 seeking is
13 	 20 	 ((S\NP)\(S\NP))/NP 	 2 	 seeking in
15 	 13 	 (S[ng]\NP)/NP 	 2 	 approvals seeking
15 	 14 	 N/N 	 1 	 approvals regulatory
15 	 17 	 (S[b]\NP)/NP 	 1 	 approvals enter <XB>
17 	 16 	 (S[to]\NP)/(S[b]\NP) 	 2 	 enter to
19 	 17 	 (S[b]\NP)/NP 	 2 	 market enter
19 	 18 	 NP[nb]/N 	 1 	 market that
22 	 20 	 ((S\NP)\(S\NP))/NP 	 3 	 U.S. in
22 	 21 	 NP[nb]/N 	 1 	 U.S. the
24 	 20 	 ((S\NP)\(S\NP))/NP 	 3 	 Japan in
<\s>
<s id="wsj_0552.40"> 18
1 	 0 	 N/N 	 1 	 Bergsma Mr.
1 	 2 	 (S[dcl]\NP)/S[dcl] 	 1 	 Bergsma said
3 	 4 	 (S[dcl]\NP)/(S[to]\NP) 	 1 	 Akzo hopes
3 	 6 	 (S[b]\NP)/NP 	 1 	 Akzo have <XB>
4 	 2 	 (S[dcl]\NP)/S[dcl] 	 2 	 hopes said
5 	 4 	 (S[dcl]\NP)/(S[to]\NP) 	 2 	 to hopes
6 	 5 	 (S[to]\NP)/(S[b]\NP) 	 2 	 have to
6 	 16 	 ((S\NP)\(S\NP))/NP 	 2 	 have in
7 	 6 	 (S[b]\NP)/NP 	 2 	 approval have
7 	 9 	 (S[b]\NP)/NP 	 1 	 approval sell <XB>
9 	 8 	 (S[to]\NP)/(S[b]\NP) 	 2 	 sell to
9 	 13 	 ((S\NP)\(S\NP))/NP 	 2 	 sell in
12 	 9 	 (S[b]\NP)/NP 	 2 	 pill sell
12 	 10 	 NP[nb]/N 	 1 	 pill its
12 	 11 	 N/N 	 1 	 pill Marvelon
15 	 13 	 ((S\NP)\(S\NP))/NP 	 3 	 U.S. in
15 	 14 	 NP[nb]/N 	 1 	 U.S. the
17 	 16 	 ((S\NP)\(S\NP))/NP 	 3 	 1992 in
<\s>
<s id="wsj_0552.41"> 14
0 	 2 	 (S[dcl]\NP)/NP 	 1 	 Akzo has
2 	 1 	 (S\NP)/(S\NP) 	 2 	 has also
4 	 2 	 (S[dcl]\NP)/NP 	 2 	 operations has
4 	 3 	 N/N 	 1 	 operations small
4 	 5 	 (NP\NP)/NP 	 1 	 operations in
7 	 5 	 (NP\NP)/NP 	 2 	 tests in
7 	 6 	 N/N 	 1 	 tests diagnostic
10 	 5 	 (NP\NP)/NP 	 2 	 drugs in
10 	 9 	 N/N 	 1 	 drugs generic
13 	 5 	 (NP\NP)/NP 	 2 	 products in
13 	 12 	 N/N 	 1 	 products veterinary
<\s>
<s id="wsj_0552.42"> 11
1 	 0 	 N/N 	 1 	 products Veterinary
1 	 2 	 (S[dcl]\NP)/(S[ng]\NP) 	 1 	 products are
1 	 3 	 (S[ng]\NP)/NP 	 1 	 products showing <XB>
2 	 10 	 (S[dcl]\S[dcl])\NP 	 1 	 are said
3 	 2 	 (S[dcl]\NP)/(S[ng]\NP) 	 2 	 showing are
5 	 4 	 (N/N)/(N/N) 	 2 	 strong especially
6 	 3 	 (S[ng]\NP)/NP 	 2 	 growth showing
6 	 5 	 N/N 	 1 	 growth strong
9 	 8 	 N/N 	 1 	 Bergsma Mr.
9 	 10 	 (S[dcl]\S[dcl])\NP 	 2 	 Bergsma said
<\s>
<s id="wsj_0552.43"> 10
0 	 4 	 (S[dcl]\PP)/NP 	 1 	 Among is
3 	 0 	 PP/NP 	 1 	 products Among
3 	 1 	 NP[nb]/N 	 1 	 products the
3 	 2 	 N/N 	 1 	 products leading
7 	 4 	 (S[dcl]\PP)/NP 	 2 	 shot is
7 	 5 	 NP[nb]/N 	 1 	 shot a
7 	 6 	 N/N 	 1 	 shot flu
7 	 8 	 (NP\NP)/NP 	 1 	 shot for
9 	 8 	 (NP\NP)/NP 	 2 	 horses for
<\s>
